May 28, 2019 (Philadelphia, PA) – Dilworth Paxson LLP announced today the addition of partner Nanda Kumar, J.D., Ph.D. to the firm’s Intellectual Property (IP) group, resident in its Princeton and Philadelphia offices.
“We couldn’t be more thrilled to welcome Nanda to the firm,” said Dilworth Chairman and CEO Ajay Raju. “Having had the privilege to work alongside Nanda at Reed Smith, I know first-hand not only the depth and array of Nanda’s talents, but the profound distinction, respect and trust he’s earned from his clients and fellow practitioners alike. As our pharma and biotech practice expands, our clients are demanding precisely the kind of sophisticated, expert representation that has defined Nanda’s career. With dual residency in Dilworth’s offices along the I-95 corridor, Nanda will be an indispensable complement both to our burgeoning tech practice in Philadelphia, and to our established pharma and biotech practice in Princeton."
Kumar concentrates his practice on intellectual property law and litigation with particular emphasis on patent litigation. He provides strategic assistance for building IP assets and managing complex patent portfolios including the preparation, filing and prosecution of patent applications related to small molecule, formulations, nucleic acids, gene therapy, vaccines, protein-protein interactions, nanoparticle technology, immunotherapy and diagnostic agents. He delivers patent analysis and opinions related to inventorship, patentability, IP due diligence, infringement and validity, and freedom-to-operate reviews. Kumar also assists clients with IP and regulatory issues in the context of Orange Book listing and Hatch-Waxman Amendments to the Federal Food, Drug & Cosmetic Act.
Kumar has wide-ranging experience in patent infringement litigation related to pharmaceutical, chemical and biotechnology industries. His IP and life science experience includes assisting clients with the structuring and negotiating of confidentiality agreements, license agreements, consulting and non-compete agreements, product development and commercialization agreements, supply agreements and asset purchase agreements.
Prior to entering the field of law, Kumar held senior scientist research positions in the U.S. life sciences industry and was a Post-Doctoral Research Fellow at The Center for Agricultural Molecular Biology, Rutgers University; The Biotechnology Center of Indian Agricultural Research Institute; and The Tata Energy Research Institute. His scientific studies and research focused primarily on biology, biochemistry, genetics, biotechnology and molecular biology.
Kumar is a graduate of Temple University School of Law (J.D.), University of Delhi, India (Ph.D.) and Andhra University, India (M.Sc.).